Sidebar

 TRACEGET iliustracija i

 

Project No. 02-002-P-0001 “Implementation of Mission-Based Science and Innovation Programmes”
Project number: 02-002-P-0001

Project promoter: Innovation Agency Lithuania

Project partners:

  • Kaunas University of Technology Consortium (Vilnius Gediminas Technical University, Mykolas Romeris University, Association Infobalt, UAB Devslate Group, UAB Novian Pro, Lithuanian Cybercrime Competence and Research Centre, UAB Transcendent Group Baltics, UAB Getweb, UAB Acrux Cyber Services, UAB NRD CS, Baltic Institute of Advanced Technology)

  • Vilnius Gediminas Technical University Consortium (Vilnius Gediminas Technical University, Kaunas University of Technology, Lithuanian Confederation of Industrialists, Lithuanian Innovation Centre, Sunrise Valley Science and Technology Park, Kaunas Science and Technology Park, UAB SG Dujos Auto, UAB Arginta, UAB 3D Creative, UAB Ekobazė, UAB Provectus Redivivus, AB Kelių priežiūra, UAB Soli Tek R&D, UAB Nanoversa)

  • Vilnius University Consortium (Vilnius University, Vilnius University Hospital Santaros Klinikos, State Research Institute Centre for Physical Sciences and Technology, UAB Femtika, UAB Droplet Genomics, UAB Caszyme, UAB Cureline Baltic, UAB Vugene)

Project description:
The project “Implementation of Mission-Based Science and Innovation Programmes” is implemented in three priority mission areas in line with Smart Specialisation priorities:

  • “Safe and Inclusive e-Society” – implemented by the Kaunas University of Technology Consortium;

  • “Smart and Climate-Neutral Lithuania” – implemented by the Vilnius Gediminas Technical University Consortium;

  • “Innovations for Health” – implemented by the Vilnius University Consortium.

The missions in different areas promote joint science–business collaboration projects, development and commercialisation of business and research ideas through start-ups/spin-offs, fundamental or early-stage research, and addressing existing service and infrastructure gaps for R&D activities at higher technology readiness levels. The project will also address the lack of incubators for spin-offs/start-ups, prototyping spaces, and pilot production lines.

The activities of the project will be implemented until April 2026. During this period, 3 competence centres (one in each mission area) will be established, 23 R&D projects implemented, 41 prototypes and 32 unique products developed, 19 international patent applications submitted, 55 scientific publications published, and 21 start-ups/spin-offs established.

Within the theme “Innovations for Health”, the Vilnius University Consortium aims to establish a Gene Technology Competence Centre, bringing together clusters of advanced scientific equipment (next-generation sequencing and bioinformatics, cytometry and cell sorting, microscopy and imaging, cell culture, microbiology, bioengineering, and mass spectrometry) as well as multidisciplinary scientific expertise. This will ensure the effective implementation of new biomedical programmes and the improvement of existing treatment strategies, with particular focus on age-related diseases and cancer. Alongside advanced infrastructure and a business-type management structure, the consortium seeks to positively impact national R&D progress, healthcare, and the economy.

The consortium is implementing 7 mission-driven R&D projects aimed at strengthening multidisciplinary scientific expertise, creating and offering relevant R&D products, and generating new scientific knowledge in the following areas:

  • U-LAVS – Ultra-fast laser-induced in vitro DNA fragment synthesis

  • ONCOINTEGRA – Development of clinical multiomics platforms for cancer diagnostics and advanced therapeutic solutions

  • GET-TOOLS – Improving genome editing by developing TnpB and miniature RNA-guided tools

  • HEMATO – Creation of a universal collection of immunocompatible cells for cell therapies

  • IMMUNO – Innovative cell immunotherapy tools for cancer treatment

  • SECURE – Safer and smaller genome-editing tools for in vivo treatment of genetic eye diseases

  • SINGLET – Single-cell multiomics and microfluidics for biomedical applications

Project objectives:

  • “Safe and Inclusive e-Society” – to increase cyber resilience and reduce risks of privacy breaches and personal data leaks, thus improving Lithuania’s cybersecurity and ensuring a safer, more inclusive digital society.

  • “Smart and Climate-Neutral Lithuania” – to improve environmental quality and reduce air pollution by contributing to the reduction of greenhouse gas emissions in Lithuania, promoting sustainable solutions in the construction sector, and accelerating the transformation of the construction market towards sustainability and zero waste.

  • “Innovations for Health” – to establish the Gene Technology Competence Centre.

Project activities:

  • Investments in competence centres – establishment of 3 competence centres (construction and acquisition of R&D equipment);

  • Joint mission programmes – implementation of 23 R&D projects;

  • Innovation support and consultancy services.

Project value: EUR 94.728 million
Project funding: EUR 88.530 million (funded by the Economic Recovery and Resilience Facility “NextGenerationLT” and the State Budget of the Republic of Lithuania)

 

GMKC pastatas